Introduction
Daniel Belostock is a partner in the firm’s Corporate practice group and a member of the M&A and Private Equity teams. He advises global strategic acquirers, private equity sponsors, family investment offices, corporate venture investors, and sector-focused venture funds on complex M&A and strategic investment transactions, with particular depth in cross-border deals and technology-driven industries including healthcare and life sciences, advanced and digital technology, industrials and chemicals.
My focus
I advise clients across four interconnected areas:
CROSS-BORDER STRATEGIC ACQUISITIONS
I serve as lead deal counsel for multinational acquirers executing repeat acquisition strategies in the US—including companies listed on the London Stock Exchange, Tokyo Stock Exchange, and NYSE. This work involves managing the interplay between US deal mechanics, foreign regulatory considerations, and multi-jurisdictional team coordination. I have guided Fortune Global 500 companies through initial US market entry, bolt-on acquisitions, strategic divestitures, and acquisition strategies that increasingly incorporate strategic venture investment alongside traditional M&A.
PRIVATE EQUITY AND SPONSOR-SIDE TRANSACTIONS
I represent financial sponsors and their portfolio companies in middle-market and upper middle-market platform acquisitions, add-on strategies, debt financings, strategic ventures, and exit transactions, with particular depth in life sciences, chemicals, industrial technology, and business services. I also advise on preferred stock and convertible debt financings, minority recapitalizations, growth equity investments, and the formation of committed capital funds and special purpose vehicles.
HEALTHCARE AND LIFE SCIENCES M&A
A significant portion of my practice involves transactions at the intersection of healthcare, technology, and distribution where deal execution requires navigating overlapping regulatory regimes alongside commercial and financial structuring. I advise both strategic acquirers entering this sector and sponsor-backed companies scaling within it, across medical devices, health technology and AI, pharmaceutical services, and home medical supply distribution.
TECHNOLOGY, INFRASTRUCTURE, AND STRATEGIC VENTURE INVESTMENTS
I advise family investment offices, sector-focused venture capital funds, and corporate venture arms on venture financings, growth equity investments, and strategic acquisitions in semiconductors, AI, digital and physical infrastructure technology, and advanced energy systems. Many of these investors operate across the full capital spectrum, from venture-stage investments through growth equity and strategic acquisitions.
Representative experience
At Nixon Peabody
- Represented Perimeter Solutions (NYSE:PRM), a global leader in fire safety and specialty solutions, in its acquisition of Medical Manufacturing Technologies LLC from Arcline Investment Management
- Represented Halma plc (LSE: HLMA), a UK-headquartered global group of life-saving technology companies, in several transactions including its acquisitions of E2S (hazard detection devices), TeDan (surgical medical devices), and Rovers (women's health medical devices) and its divestiture of Apollo America (fire and life safety services)
- Represented Sumitomo Corporation of Americas (subsidiary of Sumitomo Corporation, listed on the Tokyo Stock Exchange), a Fortune Global 500 company, in its strategic entry and continued expansion into the US healthcare market—including its acquisition of ActivStyle from AdaptHealth (NASDAQ: AHCO), its strategic equity investment in Vast Medical Holdings (owner of Quest Health Solutions), and its subsequent increased stake in Vast Medical Holdings
- Represented Globant (NYSE: GLOB), a global digitally native technology company, in multiple add-on acquisitions in AI, digital transformation, and healthcare technology—expanding Globant’s capabilities in AI automation, service experience optimization, and digital and cognitive transformation for healthcare and life sciences organizations
- Advised a leading family investment office, on strategic venture investments in technology, AI, digital infrastructure, and advanced materials sectors
- Advised a semiconductor-focused venture capital firm, on venture investments across the semiconductor value chain
- Advised an early-stage venture capital firm, on venture financings and growth investments in AI and software companies transforming infrastructure, construction technology, and the built world
- Advised strategic investors on emerging technology investments in advanced energy systems, including fusion technology
Prior to Nixon Peabody
- Represented SK Capital Partners in acquisitions of portfolio companies in the specialty chemicals, advanced materials, and pharmaceuticals sectors, including Foremark Performance Chemicals, Tri-Tex Co., Noramco, and Tasmanian Alkaloids
- Represented Seaspan Corporation, a leading independent charter owner and operator of containerships, in its acquisition of APR Energy Limited, a global leasing business operating gas turbines and power generation equipment
- Represented Unilever PLC in strategic acquisitions and divestitures
- Represented Halma plc in its acquisition of PeriGen, a leader in artificial intelligence, medical, and health technology
- Represented Globant in add-on acquisitions including providers of innovative technology solutions in the fraud prevention and identity protection space
- Represented BTG plc, a UK-based global specialist healthcare company, in acquisitions including Novate Medical (Ireland) and an investment and option to acquire Veran Medical Technologies (early lung cancer diagnostics)
- Represented Merck & Co. and Merck Global Health Innovation Fund in strategic acquisitions and corporate venture financings in health technology and pharma
- Represented Comcast Corporation and Comcast Ventures in strategic acquisitions and corporate venture financings in media technology and infrastructure
- Represented Cerberus Capital Management in acquisitions in the advertising and food services sectors
- Represented Carlyle-affiliated funds and portfolio companies in add-on acquisitions for a cloud-based business technology and intelligence platforms
Looking ahead
Many of the most interesting middle-market transactions emerging today reflect a growing intersection between cross-border strategic investment and the acquisition of technology capabilities. Global strategic acquirers are increasingly deploying capital into US healthcare, industrial, and technology infrastructure platforms through a mix of control acquisitions, minority investments, and corporate venture partnerships. As a result, deal structures are becoming more layered, with traditional M&A mechanics increasingly combined with venture-style investment terms and cross-border regulatory considerations.
What is notable is where technology is showing up. In many cases the target company is not a pure-play technology business, but an industrial, healthcare, or specialty manufacturing platform where capabilities such as AI, data engineering, and digital infrastructure are becoming strategically important. As global strategic buyers compete with private equity, venture and growth investors for these technology-enabled businesses, transactions increasingly require an integrated approach to cross-border deal execution, sector-specific regulatory issues, and technology-driven acquisition strategy.
In the news
- St. Louis Business Journal
Fire retardant maker completes $685 million acquisition of medical device company
Jan 23, 2026This article mentions NP for representing Perimeter Solutions in its acquisition of Medical Manufacturing Technologies LLC for $685 million. The NP team representing Perimeter Solutions was led by New York City Corporate partners Kevin Grant, co-leader of the M&A and Corporate Transactions team, and Dan Belostock, and associates Pat Toolan, Clara Robertson and Matt Morris. The team also included Los Angeles Corporate partner Shahzad Malik, Washington, DC Complex Disputes partner Brian Whittaker, and Boston partner and Government Investigations & White-Collar Defense deputy practice group leader Hannah Bornstein.
- The Deal
Arcline sells medical device parts maker MMT to Perimeter
Dec 11, 2025The following article mentions NP for representing Perimeter Solutions in its definitive agreement to acquire Medical Manufacturing Technologies LLC for $685 million. The NP team representing Perimeter Solutions was led by New York City Corporate partners Kevin Grant, co-leader of the M&A and Corporate Transactions team, and Dan Belostock, and associates Pat Toolan, Clara Robertson, and Matt Morris.
- Mergers & Acquisitions
Perimeter Solutions purchases MMT from Arcline for $685 million
Dec 11, 2025The following article mentions NP for representing Perimeter Solutions in its definitive agreement to acquire Medical Manufacturing Technologies LLC for $685 million. The NP team representing Perimeter Solutions was led by New York City Corporate partners Kevin Grant, co-leader of the M&A and Corporate Transactions team, and Dan Belostock, and associates Pat Toolan, Clara Robertson, and Matt Morris
- Law360
Four firms guide as Arcline exits medical tech company in $685 million deal
Dec 11, 2025The following article mentions NP for representing Perimeter Solutions in its definitive agreement to acquire Medical Manufacturing Technologies LLC for $685 million. The NP team representing Perimeter Solutions was led by New York City Corporate partners Kevin Grant, co-leader of the M&A and Corporate Transactions team, and Dan Belostock, and associates Pat Toolan, Clara Robertson, and Matt Morris.
- Law360
Nixon Peabody leads Halma in £230 million buy
Dec 5, 2025This article mentions New York City Corporate partner Dan Belostock for representing Halma in its acquisition of hazard detection device maker E2S for £230 million. The NP team also included Corporate partners Kevin Grant of New York City, Alexandra Lopez-Casero of Boston, and Damian Myers of Washington, DC; counsel Lisa Perri of New York City, David Crosby of Boston, and Courtney New of Providence; associate Christina Porras of Washington, DC, and paralegals Delaney Jaffarian of Rochester and Astrid McGruder of Chicago; Government Investigations & White-Collar Defense partners Joe Maher of Washington, DC and Mark Knights of Manchester; Rochester Privacy & Technology deputy practice group leader Jenny Holmes; Los Angeles Intellectual Property practice group leader Seth Levy and associate Vince Capati; Washington, DC Complex Disputes partner Brian Whittaker; Rochester Affordable Housing & Real Estate counsel Jennifer Berrios; Labor & Employment counsel Hillary Baca of San Francisco and senior attorney Shelagh Michaud of Providence; and Library & Research Services regional manager John Campbell.
- The Deal
Saothair Capital carves our Apollo America from Halma
July 29, 2025The following article mentions NP for representing Halma Holdings Inc. in the sale of fire and life safety services provider Apollo America Inc. to Saothair Capital Partners LLC. The NP team includes New York City partner Dan Belostock and counsel Lisa Perri, and Chicago associate Kelly Glynn, all of the Corporate practice.
- Mergers & Acquisitions
Saothair Capital Partners buys AAI from Halma
July 28, 2025The following article mentions NP for representing Halma Holdings Inc. in the sale of fire and life safety services provider Apollo America Inc. to Saothair Capital Partners LLC. The NP team includes New York City partner Dan Belostock and counsel Lisa Perri, and Chicago associate Kelly Glynn, all of the Corporate practice.
- Mergers & Acquisitions
The dark side of dealmaking
May 13, 2024This article covers unconventional strategies and tactics that are emerging for dealmakers as they navigate uncertainty around valuations and liquidity. New York City Corporate partners Kevin Grant, co-leader of the M&A and Corporate Transactions team, and Dan Belostock discuss the highly structured nature of deals as parties have become more risk adverse, and some of the various tactics that are gaining steam with buyers and sellers.
- Law360
Healthcare attorneys turn attention to material adverse change
This article covers the prevalence of material adverse change (MAC) clauses in life sciences M&A contracts and how companies are approaching them. New York City Corporate partner Dan Belostock, a member of NP’s M&A and Private Equity teams, discusses how longer timelines for deals to close require attorneys to think more about MAC clauses today than before, noting that litigation focuses on MAC clauses isn’t very common.April 30, 2024 - Law360
UK safety biz Halma buys medical tool maker for $89 million
Dec 20, 2023This article mentions NP for representing Halma PLC in its acquisition of TeDan, a group of companies that develop, manufacture, and supply medical devices to surgeons. The NP deal team was led by New York City Corporate partner Dan Belostock and also included Corporate partners Alexandra Lopez-Casero and Thomas McCord of Boston, Kevin Grant of New York City, and Shahzad Malik of Los Angeles; Boston Government Investigations & White-Collar Defense partners Hannah Bornstein and Brian French; Boston Labor & Employment partner Jeff Gilbreth; Los Angeles Intellectual Property partner Seth Levy; Rochester Privacy & Technology counsel Jenny Holmes and Boston Corporate counsel David Crosby; Corporate associates Brian Kenney of Washington, DC and Tim Sharkey of New York City; Chicago IP associates Ben Rosborough and Eliana Torres; Los Angeles Labor & Employment associate Alice Kwak; Chicago IP senior paralegal Tim Fiester; and Chicago Corporate paralegal Astrid McGruder.
- Crain’s New York Business
People on the move
New York City Corporate partners Kevin Grant and Dan Belostock are featured in this article for their recent arrival to NP, noting their focus on middle-market M&A and private equity transactions and providing additional detail on their practices.March 28, 2022 - The Deal
Movers & Shakers: DLA pair joins Nixon Peabody
New York City Corporate partners Kevin Grant and Daniel Belostock are featured in this column for their move to Nixon Peabody, mentioning their practice focus areas as well as details from prior work experience and education. The article notes that Kevin returns to NP after beginning his career at the firm as an associate.March 10, 2022 - Bloomberg Law
Wake up call
The following news coverage features the arrival of New York City Corporate partners Kevin Grant and Daniel Belostock to Nixon Peabody, mentioning that Kevin returns to NP after beginning his career at the firm as an associate.March 10, 2022 - New York Law Journal
On the move
The following news coverage features the arrival of New York City Corporate partners Kevin Grant and Daniel Belostock to Nixon Peabody, mentioning that Kevin returns to NP after beginning his career at the firm as an associate.March 9, 2022
Admitted to practice
New Jersey
New York
Education
Harvard Law School, J.D.
Rutgers University, B.A.
Recognition
- Recommended in The Legal 500 United States 2023 editorial for M&A/corporate and commercial—M&A: middle-market (sub-$500m)
Insights And Happenings
View AllProfessionals in the Practice Area
View AllAmy O'Keefe
Partner / Co-Leader, Women in Dealmaking- Boston
- Boston +1 617.345.1106
- aokeefe@nixonpeabody.com
-
Gary I. Levenstein
Partner- Chicago
- Chicago +1 312.977.4108
- Mobile +1 312.953.8238
- gilevenstein@nixonpeabody.com
-
